Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17A | Q9UEE5 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | FERMT2 | Q96AC1 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | STK17B | O94768 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28709080 | 0.98 | STK17A (0.49) | STK17AMEN1KMT2ACYP1A2TSHR | |
| SCHEMBL27319329 | 0.87 | STK17A (0.46) | STK17AMEN1KMT2ACYP1A2TSHR | |
| SCHEMBL11348193 | 0.86 | STK17A (0.55) | STK17AMEN1KMT2AFERMT2MAPT | |
| SCHEMBL9639726 | 0.85 | MAPT (0.55) | MEN1KMT2ACYP1A2NPC1CYP2D6 | |
| Fumaric Acid SCHEMBL6446108 | 0.84 | TAAR1 (0.49) | STK17AMEN1KMT2ACYP1A2TSHR | |
| Maleic Acid SCHEMBL6446102 | 0.84 | TAAR1 (0.49) | STK17AMEN1KMT2ACYP1A2TSHR | |
| SCHEMBL3029679 | 0.83 | MEN1 (0.47) | MEN1KMT2ACYP1A2NPC1CYP2D6 | |
| SCHEMBL11935538 | 0.83 | STK17A (0.52) | STK17AMEN1KMT2AFERMT2STK17B | |
| SCHEMBL4023262 | 0.83 | STK17A (0.52) | STK17AMEN1KMT2AFERMT2STK17B | |
| SCHEMBL16312662 | 0.80 | MEN1 (0.44) | MEN1KMT2ACYP1A2MAOBTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119612731-B | Cationic etherifying agent composition for sewage treatment and preparation method thereof | 东营市泽澳化工有限责任公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119612731-A | Cationic etherifying agent composition for sewage treatment and preparation method thereof | 东营市泽澳化工有限责任公司 | 2025-03-14 | — | — | CN | claimed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | claimed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | claimed |
| EP-1971600-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK Holdings Co., Ltd. (KR) | 2008-09-24 | — | — | EP | claimed |
| WO-2007078113-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK HOLDINGS CO., LTD. (KR) | 2007-07-12 | — | — | WO | claimed |
| CN-119612731-B | Cationic etherifying agent composition for sewage treatment and preparation method thereof | 东营市泽澳化工有限责任公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119612731-A | Cationic etherifying agent composition for sewage treatment and preparation method thereof | 东营市泽澳化工有限责任公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-111440205-B | Biboric acid diol ester, preparation method thereof, intermediate thereof and application thereof | 中国科学院上海有机化学研究所 | 2022-10-04 | — | — | CN | disclosed |
| CN-111440205-A | Biboric acid diol ester, preparation method thereof, intermediate thereof and application thereof | 中国科学院上海有机化学研究所 | 2020-07-24 | — | — | CN | disclosed |
| US-20200131139-A1 | SMALL MOLECULE INHIBITORS OF BCL-2- ASSOCIATED DEATH PROMOTER (BAD) PHOSPHORYLATION | BANGALORE UNIVERSITY (IN) | 2020-04-30 | — | — | US | disclosed |
| CN-106336506-B | A kind of gasoline cleaning agent polyetheramine and its synthetic method | 深圳市广昌达石油添加剂有限公司 | 2019-01-15 | — | — | CN | disclosed |
| US-9663537-B2 | Chemokine receptor antagonists and methods of use | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| EP-0443862-A1 | Triamine derivatives and their acid-addition salts | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4977167-A | Alzheimer*s disease | SHIONOGI & CO., LTD. (JP) | 1990-12-11 | — | — | US | disclosed |
| EP-0304330-A1 | Carbamoylpyrrolidone derivatives, their use and preparation | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1989-02-22 | — | — | EP | disclosed |
| EP-0114374-B1 | SUBSTITUTED 4-AMINOMETHYLENE CHROMANS OR CHROMENES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINES | BAYER AG (DE) | 1986-07-23 | — | — | EP | disclosed |
| US-4563458-A | CIRCULATORY SYSTEM DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-01-07 | — | — | US | disclosed |
| EP-0114374-A1 | Substituted 4-aminomethylene chromans or chromenes, process for their preparation and their use in medicines | BAYER AG (DE) | 1984-08-01 | — | — | EP | disclosed |
| US-4356322-A | ADRENERGIC STIMULANTS; CARDIOTONIC AGENTS | VEB ARZNEIMITTELWERK DRESDEN (DD) | 1982-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131139-A1 | SMALL MOLECULE INHIBITORS OF BCL-2- ASSOCIATED DEATH PROMOTER (BAD) PHOSPHORYLATION | BAD, BCL2, BCL2A1 | STK17A 831/4885MEN1 1602/4885KMT2A 1623/4885 |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | WNT3A, WNT1, WNT3 | STK17A 245/4885MEN1 4845/4885KMT2A 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.